Andrew Reardon, CLO & Secretary at LIGAND PHARMACEUTICALS INC (LGND), sold 1,897 shares at $104.00 ($194K) on 2025-05-15, disclosed to the SEC on 2025-06-02.
Open-market sale of $194k LGND by CLO & Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $100.16 | 897 | $90K | 46.3% |
| 2 | $104.00 | 1,000 | $104K | 53.7% |
| Total | $102.18 avg | 1,897 | $194K | 100% |
| Filing → |
| LGND | SELL | 2026-08-04 | $1.4M | — | Filing → |
| LGND | SELL | 2026-07-06 | $1.6M | — | Filing → |
| LGND | SELL | 2026-06-02 | $1.1M | — | Filing → |